As a key factor in the ER stress response, existing research suggests that the overexpression of DERL3 is associated with aggressive phenotypes in breast cancer cells and is implicated in the occurrence and progression of lung adenocarcinoma [12,15]. Here, DERL3 is linked to breast cancer.